- Approval Id
- 255628a3ec50b480
- Drug Name
- SOFIDROX CAPSULE 500 mg
- Product Name
- SOFIDROX CAPSULE 500 mg
- Approval Number
- SIN11665P
- Approval Date
- 2001-09-13
- Registrant
- APEX PHARMA MARKETING PTE. LTD.
- Licence Holder
- APEX PHARMA MARKETING PTE. LTD.
- Drug Type
- Therapeutic
- Forensic Classification
- Prescription Only
- Dosage Form
- CAPSULE
- Dosage
- **Dosage and Administration**
To be administered orally. Adult and children (over 6 years), body weight more than 40 kg:
_Urinary Tract Infections:_
For acute uncomplicated lower urinary tract infections (e.g. cystitis), the usual daily dosage is 1 or 2 grams per day in a single dose. In complicated or chronic urinary tract infections, the usual dose is 1 g every 12 hours for a minimum of 7 – 10 days.
_Skin and Skin Structure Infections:_
The usual dosage is 1 gram per day in a single dose.
_Upper Respiratory Tract Infections:_
The usual dosage is 500 mg every 12 hours. For group A β-haemolytic streptococcal pharyngitis and tonsillitis, 1 gram may be given as a single, daily dose. For any infections caused by Group A β-haemolytic streptococcus, treatment should be administered for 10 days.
_Lower Respiratory Tract Infections:_
The recommended dosage is 500 mg to 1 gram every 12 hours.
Doses should be reduced in patients with impaired renal function.
- Route Of Administration
- ORAL
- Indication Info
- **Indications**
Infections due to sensitive Gram-positive and Gram-negative bacteria, including those of the biliary, respiratory, urinary tracts and of the skin.
- Contraindications
- **Contraindications**
Cefadroxil is contraindicated in patients who are sensitive to cephalosporin and in patients with acute porphyria.
- Atc Code
- J01DB05
- Atc Item Name
- cefadroxil
- Pharma Manufacturer Name
- APEX PHARMA MARKETING PTE. LTD.
- Company Detail Path
- /organization/apex-pharma-marketing-pte-ltd
